Sandhya Kortagere

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.

Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck.